![]() |
市场调查报告书
商品编码
1654643
全球热疗设备市场 - 2025 至 2033 年Global Hyperthermia Devices Market - 2025-2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球热疗设备市场规模达到 1.785 亿美元,预计到 2033 年将达到 2.931 亿美元,2025-2033 年预测期内的复合年增长率为 5.7%。
高温设备是一种用于高温治疗技术的医疗设备,该技术涉及升高身体组织的温度来治疗各种疾病,最显着的是癌症。这些设备的工作原理是将可控的热量传送到身体的目标区域,通常是肿瘤部位,以增强化疗或放疗等其他治疗方式的有效性。热量还可以改善血液循环,促进异常细胞的破坏,并激活某些治疗过程。
全球热疗设备市场正在经历显着增长,这得益于癌症发病率的上升、医疗技术的不断进步以及热疗设备的不断普及。例如,大连大学附属中山医院专门从事癌症放射、骨显微外科和肝胆外科等复杂的医学专业,最近在其 22 英亩的宽敞土地上开设了一个完整的热疗中心。热疗中心于 2021 年 3 月开业,目前经营 13 台热疗设备,并打算增加更多。此举将使其成为中国最大的肿瘤热疗中心,为癌症治疗树立新的标竿。
驱动因素与约束因素
癌症发生率上升
癌症发病率的上升极大地推动了热疗设备市场的成长,预计在预测期内仍将推动市场的发展。随着全球癌症发生率持续上升,对热疗等创新有效治疗方案的需求激增。热疗通常用作化疗和放疗等传统治疗的辅助手段,以增强其疗效并有助于更精确地瞄准肿瘤。
全球癌症负担稳定上升,世界卫生组织 (WHO) 报告称,到 2050 年癌症病例预计将增加 77%。到2040年,每年新发癌症病例数预计将上升至2,990万人。癌症病例的急剧上升对热疗等先进治疗方式的需求庞大。值得注意的是,乳癌、摄护腺癌和子宫颈癌等癌症越来越多地采用热疗疗法治疗,导致对热疗设备的需求增加。
研究表明,热疗可以增强肿瘤细胞对化疗和放射疗法的敏感性,从而增强其有效性。这种改善传统疗法效果的能力使热疗成为对患者和医疗保健提供者都有吸引力的治疗选择。随着癌症病例数量的增加,采用更有针对性和个性化的治疗方法的数量也在增加。作为综合癌症治疗计划的一部分,热疗设备在肿瘤诊所和医院中变得越来越普遍。
温度控制的技术挑战
温度控制的技术挑战是阻碍高温治疗设备市场成长的重要因素。治疗过程中实现精确、均匀、可控的加热对于确保热疗的有效性和安全性至关重要。温度调节方面的一些技术障碍可能导致治疗不一致、对健康组织的潜在损害以及不理想的治疗效果,从而限制了热疗设备的广泛应用。
热疗的主要技术挑战之一是难以实现整个肿瘤或目标组织均匀的温度分布。肿瘤的大小、形状和深度各不相同,因此很难均匀地施加热量而不使周围健康组织过热。例如,当使用微波或射频设备时,热量会在某些点积聚,产生可能损害健康组织的热点,而其他区域可能无法达到所需的治疗温度。对于深层肿瘤来说,这个问题尤其令人担忧,因为需要精确控制以避免附带损害。
The global hyperthermia devices market reached US$ 178.5 million in 2024 and is expected to reach US$ 293.1 million by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.
Hyperthermia devices are medical devices used in the therapeutic technique known as hyperthermia therapy, which involves raising the temperature of body tissues to treat various medical conditions, most notably cancer. These devices work by delivering controlled heat to targeted areas of the body, typically to tumor sites, to enhance the effectiveness of other treatment modalities like chemotherapy or radiation. The heat can also improve blood circulation, promote the destruction of abnormal cells, and activate certain therapeutic processes.
The global hyperthermia devices market is experiencing significant growth, driven by the increasing prevalence of cancer, rising advancements in medical technology and rising adoption of hyperthermia devices. For instance, the Affiliated Zhongshan Hospital of Dalian University, which specializes in sophisticated medical specialties such as cancer radiation, bone microsurgery, and hepatobiliary surgery, recently opened a complete Hyperthermia Center on its spacious 22-acre property. The Hyperthermia Center, which opened in March 2021, operates 13 hyperthermia devices and intends to grow more. This development will make it China's largest oncological hyperthermia facility, establishing a new benchmark for cancer therapy.
Market Dynamics: Drivers & Restraints
Rising prevalence of cancer
The rising prevalence of cancer is significantly driving the growth of the hyperthermia devices market and is expected to drive the market over the forecast period. As cancer rates continue to increase globally, the demand for innovative and effective treatment options, such as hyperthermia therapy, has surged. Hyperthermia is often used as an adjunct to traditional treatments like chemotherapy and radiation, enhancing their effectiveness and helping to target tumors more precisely.
The global cancer burden is steadily rising, with the World Health Organization (WHO) reporting that cancer cases are expected to increase by 77% by 2050. In 2022, there were almost 20 million new cases worldwide. By 2040, the number of new cancer cases per year is expected to rise to 29.9 million. This sharp rise in cancer cases creates a substantial demand for advanced treatment modalities like hyperthermia. Notably, cancers like breast, prostate, and cervical cancers are increasingly treated with hyperthermia therapy, leading to an uptick in demand for hyperthermia devices.
Hyperthermia therapy has been shown to enhance the effectiveness of chemotherapy and radiation therapy by sensitizing tumor cells to these treatments. This ability to improve the outcomes of traditional therapies makes hyperthermia an attractive treatment option for both patients and healthcare providers. As the number of cancer cases increases, so does the adoption of more targeted and personalized treatments. Hyperthermia devices are becoming more prevalent in oncology clinics and hospitals as part of comprehensive cancer treatment plans.
Technical challenges in temperature control
Technical challenges in temperature control are a significant factor hampering the growth of the hyperthermia devices market. Achieving precise, uniform and controlled heating during treatment is crucial for ensuring the effectiveness and safety of hyperthermia therapy. Several technical barriers in temperature regulation can lead to treatment inconsistencies, potential harm to healthy tissues, and suboptimal results, thereby limiting the widespread adoption of hyperthermia devices.
One of the primary technical challenges in hyperthermia therapy is the difficulty in achieving uniform temperature distribution across the entire tumor or targeted tissue. Tumors can vary in size, shape and depth, making it challenging to apply heat evenly without overheating surrounding healthy tissues. For instance, when using microwave or radiofrequency devices, heat can accumulate at certain points, resulting in hot spots that may damage healthy tissues, while other areas may not reach the desired therapeutic temperature. This issue is especially concerning for deep-seated tumors where precise control is needed to avoid collateral damage.
The global hyperthermia devices market is segmented based on product type, treatment type, application, end-user and region.
The microwave hyperthermia devices segment is expected to dominate the hyperthermia devices market share
Microwave hyperthermia devices utilize electromagnetic waves to generate heat within the body. These waves can penetrate deeper tissues, making them suitable for treating tumors located deep within organs, such as the prostate, liver, and pancreas. This ability to reach deeper tumors gives microwave hyperthermia a significant advantage over other modalities like infrared or ultrasound, which are typically more effective for superficial tumors. Deep tissue penetration is a key factor in the growing adoption of microwave hyperthermia devices for cancer treatment.
Microwave hyperthermia is commonly used in conjunction with radiation therapy or chemotherapy, where it enhances the effectiveness of these treatments. The heat sensitizes cancer cells, making them more susceptible to radiation or chemotherapy-induced damage. This combination has proven to increase tumor control rates by up to 30% in some cases. Microwave hyperthermia devices significantly improve outcomes when used alongside traditional cancer therapies. This makes them a preferred choice for clinicians looking for synergistic effects.
Microwave hyperthermia devices are effective for treating a broad range of cancer types, including breast cancer, prostate cancer, lung cancer, and head and neck cancers. This wide applicability helps drive their dominance in the market. For instance, in breast cancer, microwave hyperthermia has been shown to improve local tumor control when used with radiation therapy, contributing to better patient outcomes and reduced recurrence rates.
North America is expected to hold a significant position in the hyperthermia devices market share
North America has a high incidence of cancer, with the American Cancer Society estimating that in 2023, over 1.9 million new cancer cases will be diagnosed in the U.S. alone. The rising number of cancer patients drives the need for advanced therapies, including hyperthermia. The increasing cancer burden is a major catalyst for the demand for innovative treatment solutions like hyperthermia, which can be used alongside chemotherapy or radiation to enhance treatment effectiveness.
Major companies in the hyperthermia devices market, such as Gentherm and Belmont Medical Technologies, have a strong foothold in North America, further driving the growth of the market in the region. These companies have extensive distribution networks and partner with hospitals and cancer centers to integrate hyperthermia devices into their treatment regimens.
Asia-Pacific is growing at the fastest pace in the hyperthermia devices market
Cancer is a major health concern in the Asia-Pacific region, especially countries like China, India and Japan are some of the most affected. In countries like China and India, the growing prevalence of cancers such as lung, breast, and prostate cancer has significantly increased the demand for innovative and effective treatments, including hyperthermia therapy. This increasing cancer burden in APAC is a key driver for the rapid adoption of cancer therapies, including hyperthermia.
As awareness about cancer treatment options grows in APAC, healthcare providers are more likely to adopt comprehensive cancer treatment regimens, which include hyperthermia therapy as an adjunct to radiation and chemotherapy. Countries like Japan and South Korea have been early adopters of hyperthermia treatment, and there is increasing recognition of its role in improving the efficacy of traditional treatments by enhancing tumor sensitivity to radiation or chemotherapy.
Governments in the APAC region are taking proactive steps to improve cancer treatment and care. For instance, the National Cancer Center in Japan is increasingly integrating advanced treatments like hyperthermia as part of its cancer care programs. In India, the government's National Cancer Control Program aims to improve cancer treatment access, which includes the adoption of hyperthermia therapy.
The major global players in the hyperthermia devices market include Gentherm, Pyrexar Medical, Celsius42 Korea LTD, ONCOTHERM KFT., Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Dalian Orientech Co., Ltd., heckel medizintechnik GmbH, pfm medical hico gmbh, Belmont Medical Technologies and among others.
The global hyperthermia devices market report delivers a detailed analysis with 70 key tables, more than 63 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
LIST NOT EXHAUSTIVE